← Open Payments lookup

JEANNE SALADA-CONROY: Open Payments

NPI 1073518668 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,165 in 117 payments from 17 companies in 2025. Trend: 2023 $2,354 · 2024 $2,725 · 2025 $2,165

Food & beverage: $2,165
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.12$321
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$282
Otsuka America Pharmaceutical, Inc.18$250
Lundbeck LLC13$187
E.R. Squibb & Sons, L.L.C.3$175
ABBVIE INC.10$161
Vanda Pharmaceuticals Inc.6$157
Takeda Pharmaceuticals U.S.A., Inc.20$147
Teva Pharmaceuticals USA, Inc.6$141
Supernus Pharmaceuticals, Inc.3$53

Products named: REXULTI, INGREZZA, CAPLYTA, COBENFY, VRAYLAR, TRINTELLIX, AUSTEDO XR, FANAPT.

Industry payments across NY — which companies pay providers there.